Yang Liu

发表

CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment

X. Mo, Jing Ma, S. Gu, 2020, Cancer Immunology, Immunotherapy.

In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.

M. Caligiuri, H. Aguila, T. Fehniger, 2002, Blood.

Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells

J. Byrd, X. Mo, N. Muthusamy, 2019, The Journal of Immunology.

Failed Adoptive Immunotherapy with Tumor-Specific T Cells

M. Caligiuri, A. Ferketich, S. Roychowdhury, 2004, Cancer Research.

Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies.

M. Caligiuri, A. Ferketich, S. Roychowdhury, 2005, Blood.

Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

T. Mak, P. Hwu, H. Park, 2017, Cell Research.

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity.

M. Greene, yang-xin fu, Shengdian Wang, 2010, Cancer cell.

Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.

C. Liu, P. Hwu, S. Woodman, 2012, Blood.

Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected.

Lieping Chen, M. Marić, G. Yang, 1995, Journal of immunology.